Please use the filter below to search through our archived projects.
Registry to collect longitudinal data in order to better understand patient and clinical characteristics, disease progression, complications, treatment impact, and patient-reported outcomes. Read more
Study investigating safety and efficacy for dose reduced fludarabine, cyclophosphamide and i.v. obinutuzumab (G-FC3) versus oral chlorambucil and i.v. obinutuzumab (G-Clb) in previously untreated, comorbid (CIRS score ≥6), elderly (≥65 years old) patients with chronic lymphocytic leukaemia (CLL). Read more
Study Evaluating the Efficacy and Safety of Idelalisib in Combination with Obinutuzumab Compared to Chlorambucil in Combination with Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukaemia. Read more
Study to Assess the Prevalence of Iron Overload Using MRI in Patients with transfusional siderosis. Read more
Study of Recombinant Coagulation Factor VIII (rFVIII) Compared to Recombinant Human Antihaemophilic Factor VIII (rFVIII; INN: Octocog alfa) in Subjects with Hemophilia A. Read more
Study of Efficacy, Safety, and Pharmacokinetics of PEGylated Recombinant Factor VIII (BAX 855) Administered for Prophylaxis and Treatment of Bleeding in Previously Treated Patients with Severe Hemophilia A. Read more
Study of the efficacy and safety of bortezomib administered in combination with vorinostat in patients with relapsed or refractory multiple myeloma. Read more
Study to evaluate safety, pharmacokinetics and efficacy of isatuximab in combination with cemiplimab in patients with relapsed/refractory multiple myeloma. Read more
Study Comparing the Saftey and Efficacy of BAX855 Following PK-guided Prophylaxis Targeting Two Different FVIII Trough Levels in Subjects with Severe Hemophilia. Read more
Study to Assess the Safety and Efficacy of Recombinant Coagulation Factor VIII (rFVIII-SingleChain, CSL627) in Subjects with Severe Hemophilia A. Read more
Study of Fostamatinib Disodium in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura. Read more
Study of Azacitidine with or without Birinapant in subjects with MDS or CMML. Read more
Study in Patients Requiring Anti-Fungal Prophylaxis Comparing Twice a Day Dosing of Lozanoc™ 65mg capsules (Mayne) Regardless of Food with Sporanox® (Janssen) 100mg capsules under Fed Conditions. Read more
Study Evaluating the Efficacy and Safety of (LMW) Heparin/Edoxaban Versus Dalteparin in Venous Thromboembolism Associated with Cancer. Read more
Study to Evaluate Efficacy and Safety of rVWF with or without ADVATE in Elective Surgical Procedures in Subjects with Severe Von Willebrand Disease. Read more
Study to Evaluate Patient Preference with Subcutaneous Administration of Rituximab Versus Intravenous Rituximab in Previously Untreated Patients with CD20+ Diffuse Large B-Cell Lymphoma or CD20+ Follicular Non-Hodgkin’s Lymphoma Grades 1, 2 or 3A. Read more
ALXN1210 Versus Eculizumab in Complement Inhibitor Treatment-Naive Adult Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH). Read more
Registry Collection of data to evaluate safety and characterize progression of Paroxysmal Nocturnal Hemoglobinuria (PNH). Read more
Study Evaluating the Efficacy and Safety of Eltrombopag (Revolade) in Patients with Early Refractory Immune Thrombocytopenia Within 6 Months of Diagnosis. Read more
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study. Read more
A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge Patients. Read more
Study on Xarelto for Treatment of Venous Thromboembolism (VTE) and Prevention of Recurrent VTE in Patients with Active Cancer. Read more
Oral Pacritinib Versus Best Available Therapy to Treat Myelofibrosis With Thrombocytopenia. Read more